Tag: Clinical trial

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

5 May 2025 No Comments

AUSTIN, Texas, May 1, 2025 (PR Newswire) —Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical

Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss

9 April 2024 No Comments

Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), announced

Ukraine war expected to have long-lasting impact on clinical development

28 April 2022 No Comments

Ukraine war expected to have long-lasting impact on clinical development